Calcium channel blocking drug molecule co-crystal and preparation method thereof
Patent Information
- Authority / Receiving Office
- CN Β· China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- FUDAN UNIV
- Publication Date
- 2019-10-25
- Estimated Expiration
- Not applicable Β· inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the technical field of crystalline drugs, in particular to a calcium channel blocking drug molecular co-crystal and a preparation method thereof. Background technique
[0002] Amlodipine is a third-generation dihydropyridine calcium channel blocker, which is a potent and long-acting antihypertensive drug. Amlodipine is a racemic mixture of levamlodipine and dexamlodipine in a ratio of 1:1. Pharmacological studies have shown that the antihypertensive effect of levamlodipine is more than 1000 times that of dexamlodipine; Therefore, chiral split levamlodipine, as the fourth-generation calcium ion antagonist antihypertensive drug for the treatment of hypertension, is deeply trusted by doctors and patients due to its high efficacy and small side effects, and is currently a commonly used drug for the treatment of hypertension.
[0003] Due to the advantages of stability, reproducibility, bioavailability and operability, crystalline...